The Critical Last Step That’s Often Overlooked First: Closing and Automating Cryopreservation Applications

The Critical Last Step That’s Often Overlooked First: Closing and Automating Cryopreservation Applications

Tuesday, March 19, 2024 at 1:20 PM to 1:40 PM · 20 min. (Europe/London)

Cell Therapy Manufacturing [Track 10]

Presentation

Information

• Enabling high accuracy, concentration, formulation and aliquoting for cell therapy

manufacturing

• Thinking downstream while working upstream – supporting automation from wash to

fill and finish processes

• Reducing variability while producing consistent product quality – choosing the right

technology for automation

ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry. Our platform includes G-Rex® cell culture technology, the Lovo and Cue cell processing systems, and a wide range of GMP proteins, reagents, media, and gene editing technologies.

Registered attendees

Daniel Gibson

Director, Cell and Gene Therapy ServicesAnthony Nolan

Jason Jones

Global Business Development LeadCellular Origins

Patrick Hanley

Chief and Director, Cellular Therapy ProgramChildren's National Medical Center

Log in

See all the content and easy-to-use features by logging in or registering!